港股異動丨簽訂近50億元大訂單,香港航天科技大升近19%創逾1個月新高
香港航天科技(1725.HK)今日盤中大肆走強,一度升18.74%至6.21港元,股價創9月7日以來新高。消息面上,公司昨晚公吿,與Alya訂立Alya-1系統合約。據此,集團為南美洲通訊及遙感衞星星鏈(Alya-1系統)提供星鏈總體設計、衞星製造、衞星發射協調及設施以建設Alya-1系統,合約總價6.75億美元(摺合人民幣約49.35億元)。系統建設計劃分三期完成,完成期限五年。按照香港航天科技2022年度6.35億元營收算,此次訂單規模是其去年營收的近8倍。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.